STAT

Meet the modern lab: Fast, flexible, and facilitative

Drug research and manufacturing used to be more “one-size-fits-all” — with small pipelines, big batches, and global distribution. But cell and gene therapies, antibodies, and other advanced drugs are ...
Nasdaq

FDA Reissues LumiraDx Fast Lab Solutions' EUA for SARS CoV-2 RNA STAR Complete Molecular Reagents to Allow High Throughput and Asymptomatic Testing Solutions

LONDON, Dec. 1, 2021 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX) announced today that the intended use for its Food and Drug Administration (FDA) Emergency Use Authorization (EUA) SARS-CoV-2 RNA STAR ...
Nasdaq

LumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx Dual-Target SARS-CoV-2 STAR Complete and LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete

LONDON, June 8, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX) today announced that it has achieved CE Mark for two new Fast Lab Solutions molecular tests, including Dual-Target SARS-CoV-2 STAR ...
Wall Street Journal

Fast-Growing Lab Properties Attracting New Wave of Cash

The prospect of big rent increases is drawing more large property investors to the risky but fast-growing niche of biotechnology and other life-science buildings. These laboratory businesses have ...